Molecular Partners Ag · SIX:MOLN
Mark N Lampert reported a 24.13% stake in Molecular Partners Ag (SIX significant shareholder notification)
Event Nov 17, 2023 · Filed Nov 24, 2023 · Read by 6ix Oct 14, 2026
Mark N Lampert reported a 24.13% stake in Molecular Partners Ag, 8,696,205 shares on Nov 17, 2023. Filed Nov 24, 2023 (SIX significant shareholder notification).
- Stake
- 24.13%
- Shares
- 8,696,205
- What changed
- Holding notified
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Biotechnology Value Fund, L.P. | ||
| Biotechnology Value Fund II, L.P. | ||
| Biotechnology Value Trading Fund OS, L.P. | ||
| Msi Bvf Spv, LLC |
Source
Related
- Molecular Partners Ag
- Mark N Lampert
- Molecular Partners Ag shareholders
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 29, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 19, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 16, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Nov 25, 2025
- Schedule 13G · UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC · Jul 17, 2025